Soluble collagen in bovine corneal stroma was determined by homogenizing and sequentially extracting the tissue with 0.45 m NaCl, pH 7.4, 0.5 m citrate buffer, pH 4.3, and 0.5 m acetic acid. Calf cornea contains about three times more soluble collagen than cow cornea. In both calf and cow, the salt-soluble fraction contains the most collagen. Though calf corneas contain citrate and acetic acid-soluble collagen fractions, they are reduced greatly in the cow cornea. Calf corneas were incubated with 3,4–3H-proline for estimation of collagen biosynthesis and the data show that cornea has the capacity for in vitro synthesis of collagen. The tissue utilized radioactive proline slightly better when stroma alone without the epithelium was used. The specific activity of collagen was high in the salt-soluble fraction and also in the dialyzed incubation medium (containing collagen and soluble protein leached from the corneas). With the in vitro system, radioactivity was detected in the insoluble fibrous collagen in the corneas. Chelating agents, antibiotics, and other metabolic inhibitors markedly inhibited biosynthesis of collagen and other proteins. The iron chelator, α, α’-dipyridyl, selectively inhibits biosynthesis of corneal collagen.

This content is only available via PDF.
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.